Hitgen Inc. (688222.SH): Rongchuang Pioneer Fund plans to increase capital by 40 million yuan to acquire 51% stake in Moshang Intelligence.
Chengdu Xinda (688222.SH) announced that the Rongchuang Xindao Fund, established by the company, will invest 40 million yuan in Moheshang Intelligent Technology (Chengdu) Co., Ltd. ("Moheshang Intelligent") through capital increase with its own funds. Chengdu Xinda, as a limited partner in the Rongchuang Xindao Fund, will contribute 40% of the total investment. According to the partnership agreement and its ancillary agreements, this fund will be included in Chengdu Xinda's consolidated financial statements. After the capital increase, the Rongchuang Xindao Fund will acquire 51% of the target company's equity, and the target company will be included in Chengdu Xinda's consolidated financial statements.
Hitgen Inc. (688222.SH) announced that the Rongchuang Pilot Fund, established by the company, will invest 40 million yuan in MoShang Intelligent Technology (Chengdu) Co., Ltd. (referred to as "MoShang Intelligent") through capital increase. Hitgen Inc. is a limited partner in the Rongchuang Pilot Fund, with a contribution ratio of 40%. According to the fund partnership agreement and its subsidiary agreements, this fund will be included in Hitgen Inc.'s consolidated financial statements. After the capital increase, the Rongchuang Pilot Fund will acquire 51% of the target company's equity, and the target company will be included in Hitgen Inc.'s consolidated financial statements.
The target of this investment is MoShang Intelligent, which provides comprehensive services around life science data infrastructure construction, artificial intelligence (AI) model development, pharmaceutical consulting services, etc. MoShang Intelligent has three subsidiaries: MoShang Data Science (Chengdu) Medical Technology Co., Ltd. (referred to as "MoShang Chengdu"), Hydrocarbon Data Science (Chengdu) Information Technology Co., Ltd. (referred to as "Hydrocarbon Chengdu"), and MoShang Data Science (Chongqing) Information Technology Co., Ltd. (referred to as "MoShang Chongqing"). MoShang Chengdu, founded in 2020, is the core platform company of the MoShang system, focusing on high-tech enterprises that provide data services in the field of life sciences and AI solutions. The company's business covers the four core fields of biology, chemistry, pharmacy, and medicine, serving the entire chain of the life science industry including investment, project establishment, research and development, registration, production, sales, and medical services. MoShang Chengdu has obtained multiple qualifications such as high-tech enterprise and provincial-level "specialized, sophisticated, distinctive, and novel" enterprise certifications. MoShang Chongqing and Hydrocarbon Chengdu carry out data collection operations, model development, and other molecular business lines.
Related Articles
MOODY TECH HLDG (01400) has signed a memorandum of understanding with Yuanzhu Zaocheng to expand sales and customer base in the digital marketing business.
The major shareholder, West Lake Electronics Group, of Wasu Media Holding (000156.SZ) plans to reduce its shareholding by no more than 1%.
Jiangsu Hengrui Pharmaceuticals (01276): Approval granted to conduct clinical trials for injection of lysozyme microspheres.
MOODY TECH HLDG (01400) has signed a memorandum of understanding with Yuanzhu Zaocheng to expand sales and customer base in the digital marketing business.
The major shareholder, West Lake Electronics Group, of Wasu Media Holding (000156.SZ) plans to reduce its shareholding by no more than 1%.
Jiangsu Hengrui Pharmaceuticals (01276): Approval granted to conduct clinical trials for injection of lysozyme microspheres.
